• linkedin
  • Increase Font
  • Sharebar

    Urology groups reiterate support for USPSTF bill

    Legislation calls for specialist input on recommendations

    Bob GattyBob GattyWashingtonThe major organizations representing urologists are continuing their push for congressional approval of legislation designed to reform the operations of the U.S. Preventive Services Task Force (USPSTF), which in May 2012 recommended against PSA-based screening for prostate cancer.

    Ever since those recommendations were published, the AUA, the American Association of Clinical Urologists (AACU), and LUGPA (formerly the Large Urology Group Practice Association) have been pushing Congress to make certain that specialists and other health care providers are involved in the development and review of USPSTF recommendations.

    The May 2012 recommendation noted that the lifetime risk of dying from prostate cancer is only 2.8%, with 70% of deaths occurring after age 75. USPSTF said there is “convincing evidence that PSA-based screening programs result in the detection of many cases of asymptomatic prostate cancer.”

    READ: Congress cuts coverage for erection devices

    The USPSTF concluded that the rate of “over-diagnosis” is high and that many men undergo unnecessary surgery. As a result, the task force gave the use of PSA for prostate cancer screening a grade “D” and said the procedure is not recommended.

    In early March, the three major urologic groups reiterated their support for the USPSTF Transparency and Accountability Act of 2015, introduced by Reps. Marsha Blackburn (R-TN) and Bobby Rush (D-IL)—an exercise they have been going through for the past 3 years.

    NEXT: Bill requires consultation with experts

    More from Urology Times

    Narrow networks expand, raising concern

    Work force proposals may endanger patient safety, professional standards

    Self-referral, live surgery raise ethical challenges

    Bob Gatty
    Bob Gatty, a former congressional aide, covers news from Washington for Urology Times.

    0 Comments

    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available

    Poll